Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy

Cristina Zanchi; Monica Locatelli; Domenico Cerullo; Verena Aumiller; Daniela Corna; Daniela Rottoli; Steffen Schubert; Marina Noris; Susanna Tomasoni; Giuseppe Remuzzi; Carla Zoja; Ariela Benigni

doi:10.1016/j.molimm.2024.02.010

Related publications

Article2023

Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy

Edwin Wong, Carla Nester, Teresa Cavero, Alexandre Karras, Moglie Le Quintrec, Liz Lightstone, Ute Eisenberger, María José Soler, David Kavanagh, Erica Daina, Manuel Praga, Nicholas Medjeral‐Thomas, Anja Gäckler, Clara García-Carro, Andrea Biondani, Frédérique Chaperon, Kenneth Kulmatycki, Julie Milojevic, Nicholas J.A. Webb, Prasanna Kumar Nidamarthy, G. Junge, Giuseppe Remuzzi

Article2021

Amnion epithelial cells are an effective source of factor H and prevent kidney complement deposition in factor H-deficient mice

Federica Casiraghi, Pamela Yossenaidy Rodriguez Ordonez, Nadia Azzollini, Marta Todeschini, Daniela Rottoli, Roberta Donadelli, Roberto Gramignoli, Ariela Benigni, Marina Noris, Giuseppe Remuzzi

Article2024

Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy

Discussion(0)

Related publications

Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy

Amnion epithelial cells are an effective source of factor H and prevent kidney complement deposition in factor H-deficient mice

Clinical and Histological Predictors of Outcomes in C3 Glomerulopathy

Efficacy and Safety of Iptacopan in Patients with C3 Glomerulopathy: 12-Month Results from the Phase 3 APPEAR-C3G Study

Therapeutic Small Interfering RNA Targeting Complement C3 in a Mouse Model of C3 Glomerulopathy